SCHEMBL8939569

SCHEMBL8939569

CC(C)(C)OC(=O)N[C@@](C)(Cc1ccc2ccccc2c1)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 1/20 0.54
▸ CTSS P25774 1/20 0.54
▸ CTSK P43235 1/20 0.54
▸ PTPN1 P18031 1/20 0.44
▸ GABRB1 P18505 1/20 0.43
▸ GABRB2 P47870 1/20 0.43
▸ MMP1 P03956 1/20 0.42
▸ MMP9 P14780 1/20 0.42
▸ MMP13 P45452 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7856910 1.00 CTSB (0.54) CTSBCTSSCTSKPTPN1GABRB1
SCHEMBL1350802 0.85 CA12 (0.50) CTSBCTSSCTSKALDH1A1CYP3A4
SCHEMBL1350805 0.85 CA12 (0.50) CTSBCTSSCTSKALDH1A1CYP3A4
SCHEMBL1552723 0.85 CA12 (0.50) CTSBCTSSCTSKALDH1A1CYP3A4
SCHEMBL7857502 0.83 CTSS (0.52) CTSBCTSSCTSKLMNAMAPT
SCHEMBL10723235 0.82 KDM4E (0.64) CTSSCTSKKDM4EALDH1A1LMNA
SCHEMBL10723225 0.82 KDM4E (0.64) CTSSCTSKKDM4EALDH1A1LMNA
SCHEMBL21243782 0.81 CTSK (0.47) CTSKMMP13ALDH1A1CYP1A2SMN1; SMN2
SCHEMBL11375041 0.81 PPARA (0.40) CTSBCTSSCTSKKDM4EALDH1A1
SCHEMBL16447882 0.80 PPARG (0.49) CTSKMMP1MMP9MMP13LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0563132-B1 TETRAPEPTIDE DERIVATIVES AND ANALOGUES BLACK JAMES FOUNDATION (GB) 1996-02-07 — — EP disclosed
US-5486597-A GASTRIN ANTAGONIST AS ANTISECRETORY AGENTS OF GASTRIC JUICE FOR STOMACH CANCER JAMES BLACK FOUNDATION LIMITED (GB) 1996-01-23 — — US disclosed
EP-0563132-A1 TETRAPEPTIDE DERIVATIVES AND ANALOGUES. BLACK JAMES FOUNDATION (GB) 1993-10-06 — — EP disclosed
WO-1992011284-A1 TETRAPEPTIDE DERIVATIVES AND ANALOGUES THE JAMES BLACK FOUNDATION LIMITED (GB) 1992-07-09 — — WO disclosed
Send feedback